Header Logo

Connection

L JEFFREY MEDEIROS to Receptor Protein-Tyrosine Kinases

Back to Details
This is a "connection" page, showing publications L JEFFREY MEDEIROS has written about Receptor Protein-Tyrosine Kinases.
L JEFFREY MEDEIROS
Connection Strength
1.682
Receptor Protein-Tyrosine Kinases
  1. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations. Am J Clin Pathol. 2004 Sep; 122(3):348-58.
    View in: PubMed
    Score: 0.184
  2. DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. Haematologica. 2023 06 01; 108(6):1604-1615.
    View in: PubMed
    Score: 0.169
  3. Reply to "PD-L1 expression in anaplastic large cell lymphoma". Mod Pathol. 2020 06; 33(6):1234-1235.
    View in: PubMed
    Score: 0.135
  4. The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma. Br J Haematol. 2014 Nov; 167(4):514-23.
    View in: PubMed
    Score: 0.092
  5. Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med. 2009 Sep; 133(9):1383-90.
    View in: PubMed
    Score: 0.065
  6. Anaplastic Large Cell Lymphoma. Am J Clin Pathol. 2007 May; 127(5):707-22.
    View in: PubMed
    Score: 0.055
  7. p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma. Leukemia. 2005 Sep; 19(9):1663-9.
    View in: PubMed
    Score: 0.049
  8. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type. Br J Haematol. 2005 Sep; 130(5):726-8.
    View in: PubMed
    Score: 0.049
  9. Differential expression of cyclin D3 in ALK+ and ALK- anaplastic large cell lymphoma. Hum Pathol. 2005 Jul; 36(7):806-11.
    View in: PubMed
    Score: 0.049
  10. Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia. Am J Clin Pathol. 2005 Jun; 123(6):840-8.
    View in: PubMed
    Score: 0.048
  11. Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma. Leukemia. 2004 Nov; 18(11):1872-8.
    View in: PubMed
    Score: 0.047
  12. Isothermal multiple displacement amplification: a highly reliable approach for generating unlimited high molecular weight genomic DNA from clinical specimens. J Mol Diagn. 2004 Aug; 6(3):236-42.
    View in: PubMed
    Score: 0.046
  13. Absence of Epstein-Barr virus in anaplastic large cell lymphoma: a study of 64 cases classified according to World Health Organization criteria. Hum Pathol. 2004 Apr; 35(4):455-9.
    View in: PubMed
    Score: 0.045
  14. Caspase-3 activation in systemic anaplastic large-cell lymphoma. Mod Pathol. 2004 Jan; 17(1):109-16.
    View in: PubMed
    Score: 0.044
  15. c-kit is not expressed in Hodgkin disease and anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma. Blood. 2003 Dec 15; 102(13):4619-20.
    View in: PubMed
    Score: 0.044
  16. BCL-3 overexpression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Blood. 2003 Aug 01; 102(3):1146-7.
    View in: PubMed
    Score: 0.043
  17. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation. J Pathol. 2003 Jun; 200(2):240-8.
    View in: PubMed
    Score: 0.042
  18. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma. Clin Cancer Res. 2003 Mar; 9(3):1121-8.
    View in: PubMed
    Score: 0.041
  19. Clusterin expression in malignant lymphomas: a survey of 266 cases. Mod Pathol. 2002 Nov; 15(11):1221-6.
    View in: PubMed
    Score: 0.041
  20. Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections. Am J Clin Pathol. 2002 Sep; 118(3):328-34.
    View in: PubMed
    Score: 0.040
  21. Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms. Pathology. 2022 Dec; 54(7):893-899.
    View in: PubMed
    Score: 0.040
  22. Overexpression of Mcl-1 in anaplastic large cell lymphoma cell lines and tumors. Am J Pathol. 2002 Jun; 160(6):2309-10.
    View in: PubMed
    Score: 0.039
  23. Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma. Mod Pathol. 2022 03; 35(3):412-418.
    View in: PubMed
    Score: 0.038
  24. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage. Am J Pathol. 2001 Aug; 159(2):527-35.
    View in: PubMed
    Score: 0.037
  25. Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma. Hum Pathol. 2014 Oct; 45(10):1995-2005.
    View in: PubMed
    Score: 0.023
  26. Anaplastic large cell lymphoma: another entity in the differential diagnosis of small round blue cell tumors. Ann Diagn Pathol. 2009 Dec; 13(6):413-27.
    View in: PubMed
    Score: 0.017
  27. Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count. Pathol Int. 2009 May; 59(5):345-53.
    View in: PubMed
    Score: 0.016
  28. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res. 2009 Mar 15; 69(6):2550-8.
    View in: PubMed
    Score: 0.016
  29. Flow cytometric immunophenotyping of anaplastic large cell lymphoma. Arch Pathol Lab Med. 2009 Jan; 133(1):49-56.
    View in: PubMed
    Score: 0.016
  30. The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression. Exp Hematol. 2006 Dec; 34(12):1670-9.
    View in: PubMed
    Score: 0.013
  31. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res. 2006 Jul 01; 66(13):6589-97.
    View in: PubMed
    Score: 0.013
  32. Intrinsic apoptotic pathway in anaplastic large cell lymphoma. Hum Pathol. 2006 Jul; 37(7):874-82.
    View in: PubMed
    Score: 0.013
  33. Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma. Hum Pathol. 2005 Sep; 36(9):939-44.
    View in: PubMed
    Score: 0.012
  34. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Am J Pathol. 2004 Jun; 164(6):2251-8.
    View in: PubMed
    Score: 0.011
  35. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol. 2004 May 01; 22(9):1682-8.
    View in: PubMed
    Score: 0.011
  36. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma. Oncogene. 2003 Aug 21; 22(35):5399-407.
    View in: PubMed
    Score: 0.011
  37. Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma. Clin Cancer Res. 2003 Jun; 9(6):2213-20.
    View in: PubMed
    Score: 0.011
  38. Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients. Leuk Lymphoma. 2001 Sep-Oct; 42(5):969-79.
    View in: PubMed
    Score: 0.009
  39. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma. Mod Pathol. 2000 Mar; 13(3):223-8.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.